This year’s seasonal vaccine contains three influenza viruses — one A (H3N2) virus, one regular seasonal A (H1N1) virus unrelated to the swine flu strain and one B virus.
今年的季节流感疫苗含有三种流感病毒——一种甲型（H3N2）病毒，一种与猪流感毒株无关的常规季节性甲型（H1N1）病毒，以及一种乙型病毒。
It takes approximately five to six months for the first supplies of approved vaccine to become available once a new strain of influenza virus with pandemic potential is identified and isolated.
一旦鉴定并分离出具有大流行可能的流感病毒新毒株，大约需要5至6个月时间提供首批获批准的疫苗。
Extensive studies and data analysis of influenza vaccines have only found a well established causal association with the 1976 vaccine that contained an H1N1 swine-influenza-like virus.
经由对流感病毒的进一步研究和数据分析，只发现在1976年含有类似于H1N1病毒的疫苗存在一例具有完整因果联系的案例。
It's called a recombinant protein vaccine and USES an influenza virus protein that's made by genetically altering a virus that infects insect cells.
这种疫苗被称作“重组蛋白疫苗”，它采用了一种流感病毒蛋白质，这种蛋白质是通过改变一种感染昆虫细胞的病毒的基因而合成的。
Objective Study the relationship between type A influenza virus genetic variation with survival selective pressure, help for the finding of possible vaccine conserved antigen target.
目的研究甲型流感病毒基因变异与生存选择压力的关系，指导保守疫苗靶位点的寻找。
Objective Study the relationship between type A influenza virus genetic variation with survival selective pressure, help for the finding of possible vaccine conserved antigen target.
目的研究甲型流感病毒基因变异与生存选择压力的关系，指导保守疫苗靶位点的寻找。
应用推荐